Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 45,250 | 0 | 3,729 | 3,653 | 3,385 |
| Gross Profit | 45,250 | N/A | 3,729 | 3,653 | 3,385 |
| Operating Expenses | 1,436 | 5,778 | 13,063 | 21,508 | 16,529 |
| Operating Income | 43,814 | -5,778 | -9,334 | -17,855 | -13,144 |
| Other Income | 903 | -3,996 | 68 | 220 | 442 |
| Pre-tax Income | 44,717 | -9,774 | -9,266 | -17,635 | -12,702 |
| Net Income Continuous | 44,717 | -9,774 | -9,266 | -17,635 | -12,702 |
| Net Income | $44,717 | $-9,774 | $-9,266 | $-17,635 | $-12,702 |
| EPS Basic Total Ops | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| EPS Basic Continuous Ops | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| EPS Diluted Total Ops | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| EPS Diluted Continuous Ops | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| EPS Diluted Before Non-Recurring Items | 1.07 | -0.12 | -0.22 | N/A | -0.31 |
| EBITDA(a) | $43,814 | $-5,778 | $-8,673 | $-17,186 | $-12,407 |